Author: admin

  • Scientists Reverse Memory Loss by Editing Single Brain Molecule

    Scientists Reverse Memory Loss by Editing Single Brain Molecule

    IN A GROUNDBREAKING study that could transform our understanding of ageing and cognition, researchers have found a way to restore memory in aged rats by fine-tuning a single molecular process in the brain. The discovery reveals that reducing a…

    Continue Reading

  • Satellite Launched to Track Sea-Level Rise

    Satellite Launched to Track Sea-Level Rise

    Sentinel-6B is the latest satellite in the Copernicus programme; the European Commission’s world-leading Earth observation initiative delivered in partnership with the European Space Agency (ESA). It is one of a series of missions that date back…

    Continue Reading

  • BBC Sport triumphs at Broadcast Sport Awards with big wins for Women’s Sport and Gen Z audiences

    BBC Sport triumphs at Broadcast Sport Awards with big wins for Women’s Sport and Gen Z audiences

    BBC Sport is celebrating a phenomenal night of success after securing five major wins at the Broadcast Sport Awards – with women’s sport and younger audiences taking centre stage.

    BBC Sport was crowned Sports Broadcaster/Streamer of the Year,…

    Continue Reading

  • Maggi meets Sarah, Anish Kapoor takes on Ice and Suffolk seduces Spencer – the week in art | Art and design

    Maggi meets Sarah, Anish Kapoor takes on Ice and Suffolk seduces Spencer – the week in art | Art and design

    Exhibition of the week

    Maggi Hambling and Sarah Lucas
    These two very different artists became friends after meeting at the Colony Room (where else?) and now show together in an encounter of British art generations.
    Sadie Coles HQ, London, 20…

    Continue Reading

  • TuHURA Biosciences, Inc. Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

    TuHURA Biosciences, Inc. Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

    Phase 3 accelerated approval trial of IFx-2.0 as adjunctive therapy with Keytruda® (pembrolizumab) as a first-line therapy for advanced and metastatic Merkel cell carcinoma (MCC) is underway, conducted under Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA)

    Company’s Delta Opioid Receptor (DOR) technology selected for an oral presentation, along with 2 poster presentations at the 67th Annual American Society of Hematology (ASH) Annual Meeting and Exposition, taking place in Orlando, Florida on December 6-9, 2025

    TAMPA, Fla., Nov. 14, 2025 /PRNewswire/ — TuHURA Biosciences, Inc. (NASDAQ:HURA) (“TuHURA”), a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to cancer immunotherapy, today reported financial results for the Company’s third quarter ended September 30, 2025, and provided a corporate update.

    “TuHURA remains highly focused on the execution of its clinical development programs, including enrollment in our Phase 3 pivotal trial of IFx-2.0 as an adjunctive therapy to pembrolizumab in the first line treatment of patients with advanced or metastatic MCC. This accelerated, registration-directed trial, conducted under an SPA Agreement with the FDA, has the potential, if successful, to satisfy the requirements for both accelerated and regular approval without the need to conduct a post-approval confirmatory trial,” stated Dr. James Bianco, President and Chief Executive Officer of TuHURA. “In parallel to advancing our late-stage development candidate IFx-2.0, we are working with experts in the treatment of AML to complete the protocol design for our Phase 2 study of TBS-2025, our VISTA inhibiting antibody, in patients with NPM1 mutated AML. We are on track to submit our proposed Phase 2 plan to FDA next month and initiate the Phase 2 randomized study in the first quarter of next year.”

    Dr. Bianco continued, “In addition to our clinical programs, we were excited to see validation of the scientific merit related to our discovery of the potential role of the DOR expression on Myeloid Derived Suppressor Cells (MDSCs) by being selected by the Joint Program Committees of the ASH 2025 Annual Meeting for an oral presentation. We look forward to presenting our data demonstrating that the DOR is a potential novel target to reprogram the immune suppressing capabilities of MDSCs and tumor-associated macrophages (TAMs). Together with regulatory T cells (Tregs), these immunosuppressive cells are collectively responsible for acquired resistance to cancer immunotherapies. The DOR technology is the backbone of our program to develop first-in-class bi-specific, bi-functional immune modulating antibody drug conjugates (ADCs). TuHURA’s oral presentation at the ASH 2025 Annual Meeting is on December 7th at 5:15pm ET.”

    Corporate Highlights

    • Acceptance of Oral and Poster Presentations at ASH 2025 Annual Meeting and Exposition. TuHURA announced that ASH has accepted the following abstracts for presentation:
      • Oral Presentation: Delta Opioid Receptor (DOR) Expression on Myeloid-Derived Suppressor Cells (MDSCs) Represents a Novel Target to Overcome Resistance to Immune Checkpoint Inhibitors (ICIs)
      • Poster Presentation: Delta Opioid Receptor (DOR): A Novel Target for Reprogramming Tumor-Associated Macrophage (TAM) Immunosuppressive Phenotype to Overcome Acquired Resistance and Enhance the Effectiveness of Cancer Immunotherapies
      • Moffitt Cancer Center Poster Presentation: Delta opioid receptor signaling modulates myeloid suppression in Myelodysplastic Syndromes
    • Strengthening of TuHURA Team Through the Appointment of Dr. Michael Turner. In November 2025, Michael Turner, Ph.D. was appointed as Vice President of Immunology. Dr. Turner has over 20 years of experience in immunology and oncology, with experience at leading industry companies such as Sanofi Genzyme, Alkermes, Ventus Therapeutics and Third Harmonic Bio.
    • $50 Million At-The-Market (ATM) Facility Filed. In November 2025, TuHURA became eligible to file a “shelf” registration statement on Form S-3 and entered into agreement providing for an ATM facility of up to $50 Million. TuHURA will become able to sell shares under the ATM facility when the S-3 registration statement filed on November 3, 2025 becomes effective under the rules and regulations of the SEC.

    Upcoming Targeted Milestones by Program

    IFx-2.0 (Innate immune agonist)

    • Q2 2026: Anticipate preliminary results from Phase 1b/2a clinical trial of IFx-2.0 as an adjunctive therapy to pembrolizumab in first line treatment for MCC of unknown primary origin (MCCUP).
    • Q4 2026: Anticipate completion of enrollment in the randomized, placebo-controlled Phase 3 accelerated approval trial in first line treatment as adjunctive therapy to Keytruda® in advanced or metastatic MCC.
    • Q1 2027: Anticipate topline results from the Phase 3 accelerated approval trial.

    TBS-2025 (VISTA inhibiting antibody)

    • Q4 2025: Submission of the Phase 2 protocol and plan to the FDA for TBS-2025 in hematologic malignancies.
    • Q1 2026: Initiation of a Phase 2 trial of VISTA inhibiting mAb in relapsed or refractory NPM1-mutated AML in combination with a menin inhibitor.

    Lead ADC Selection

    • Q1 2026: TuHURA has developed a library of potent, highly selective DOR inhibitors to be evaluated in its MDSC assays. TuHURA expects to select a lead DOR inhibitor to conjugate to TBS-2025 for testing in preclinical models.
    • Q3 2026: Anticipates first proof of concept in-vivo results from its lead immune modulating ADC.

    Financial Results for the Three Months and Nine Months Ended September 30, 2025

    Research and development expenses were $4.9 million and $2.9 million for the three months ended September 30, 2025, and 2024, respectively.

    Net cash outflows from operating activities were ($22.1) million and ($12.1) million for the nine months ended September 30, 2025, and 2024, respectively.

    As of September 30, 2025, TuHURA’s total shares outstanding was approximately 51.2 million.

    About TuHURA Biosciences, Inc.
    TuHURA Biosciences, Inc. (Nasdaq: HURA) is a Phase 3 immuno-oncology company developing novel technologies to overcome primary and acquired resistance to cancer immunotherapy, two of the most common reasons cancer immunotherapies fail to work or stop working in the majority of patients with cancer.

    TuHURA’s lead innate immune agonist, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. TuHURA initiated a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda® (pembrolizumab) compared to Keytruda® plus placebo in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.

    In addition to its innate immune agonist product candidates, TuHURA acquired TBS-2025 in its merger with Kineta Inc. on June 30, 2025. TBS-2025 is a VISTA inhibiting mAb moving into Phase 2 development in mutNPM1 r/r AML. In addition, TuHURA is leveraging its Delta Opioid Receptor technology to develop first-in-class, bi-specific antibody drug conjugates and antibody peptide conjugates targeting Myeloid Derived Suppressor Cells to inhibit their immune-suppressing effects on the tumor microenvironment to prevent T cell exhaustion and acquired resistance to checkpoint inhibitors and cellular therapies.

    For more information, please visit www.tuhurabio.com and connect with TuHURA on Facebook, X, and LinkedIn.

    CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

    This press release contains certain “forward-looking statements” within the meaning of, and subject to the safe harbor created by, Section 27A of the Securities Act, Section 21E of the Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These Forward-looking statements are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and other future conditions. In some cases you can identify these statements by forward-looking words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “could,” “should,” “would,” “project,” “plan,” “expect,” “goal,” “seek,” “future,” “likely” or the negative or plural of these words or similar expressions. Examples of such forward-looking statements include but are not limited to express or implied statements regarding TuHURA’s expectations, hopes, beliefs, intentions or strategies regarding the future and include, without limitation, statements regarding TuHURA’s Delta Opioid Receptor Technology, its IFx-Hu2.0 product candidate and Phase 3 trial, and its TBS-2025 asset, and any developments or results in connection therewith and the anticipated regulatory pathway and timing of the foregoing development programs, studies and trials. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. You are cautioned that such statements are not guarantees of future performance and that actual results or developments may differ materially from those set forth in these forward-looking statements. Factors that could cause actual results to differ materially from these forward-looking statements are described in detail in our registration statements, reports and other filings with the SEC, which are available on the combined company’s website, and at www.sec.gov.

    The forward-looking statements and other information contained in this press release are made as of the date hereof, and TuHURA does not undertake any obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws. Nothing herein shall constitute an offer to sell or the solicitation of an offer to buy any securities.

    Investor Contact:
    Monique Kosse
    Gilmartin Group
    [email protected]

    SOURCE TuHURA Biosciences, Inc.

    Continue Reading

  • ‘Kitten Space Agency’ is the spiritual successor to ‘Kerbal Space Program’, and they have an ex-SpaceX engineer on the team (interview)

    ‘Kitten Space Agency’ is the spiritual successor to ‘Kerbal Space Program’, and they have an ex-SpaceX engineer on the team (interview)

    We often hear about how people working in the space industry first had their interest piqued by space movies and games, but someone working in the space industry for over a decade before making the jump to developing video games is a much rarer…

    Continue Reading

  • Consumers flash holiday warning signs

    Consumers flash holiday warning signs

    Shoppers walk through Manhattan on Nov. 7, 2025, in New York City.

    Spencer Platt | Getty Images

    High-income consumers are trading down, Gen Z is spending less, and low-income shoppers are still struggling, according to many consumer companies that shared their latest quarterly results in recent weeks.

    Those trends may not bode well for the big-box and mall retailers that have yet to report their earnings. That is, unless the strength of their brands — or high-income consumers who see their products as a good deal — help them transcend the gloomier consumer climate.

    While the Atlanta Fed’s GDPNow tracker is projecting 4% U.S. GDP growth in the third quarter, there are cracks showing in the economy. Earlier this month, U.S. consumer sentiment slipped to near record lows, fueled by concerns about higher prices and the federal government shutdown. Plus, private data sources show that the U.S. economy was losing jobs through late October.

    Investors will get a wider snapshot in the coming week. Some of the biggest names in retail, including Walmart, Target, Gap and Home Depot, will report their latest earnings and provide insights into how spending during the critical holiday season is shaping up.

    According to credit card data from equity research firm and bank Truist, sales have softened in recent weeks across many of the retailers that it watches. Sales trends slowed at Walmart, Home Depot and Lowe’s in October after after they saw solid sales in August and September, according to Truist.

    Wall Street has noticed slower spending, too. Michael Baker, a retail analyst for D.A. Davidson, said he now expects weaker holiday spending than he did before as consumers face a challenging mix of higher tariffs, slower job growth and pressure on lower-income households.

    He expects holiday sales to grow in the high 3% range year over year, down from the firm’s previous view that holiday sales growth would accelerate from last year’s 4.3% increase.

    “There’s just a lot of headwinds building for the consumer and a lot of the data we track [at retailers] was just really bad in September and even worse in October,” he said.

    High-income shoppers trade down

    For roughly two years, executives have warned investors that low-income consumers were spending less, dining out less frequently and growing picky about their shopping.

    Now there are more signs that high-income shoppers are watching their budgets, too. That trend could help some of the retailers reporting in the weeks ahead, such as Walmart, Dollar General and Dollar Tree, while hurting others like Target and Best Buy.

    The fast-food industry saw traffic from high-income diners climb by nearly double digits in the third quarter, according to McDonald’s CEO Chris Kempczinski. McDonald’s, often seen as bellwether for the economy, is gaining share with high-income consumers, thanks to deals like its Extra Value Meals, he said on the company’s conference call earlier this month.

    “I think sometimes there’s this idea that value only matters to low-income [consumers],” Kempczinski said. “But value matters to everybody, whether you’re upper income, middle income, lower income, feeling like you’re getting good value for your dollar is important.”

    Sign at the entrance to an Applebee’s in Midtown Manhattan.

    Erik McGregor | Lightrocket | Getty Images

    Fast-food chains aren’t the only ones benefitting from higher-income diners trading down.

    Dine Brands, which owns Applebee’s and IHOP, is seeing a similar trend. With a 2 for $25 promotion at Applebee’s and a $6 value menu at IHOP, the casual-dining chains are pulling customers away from higher-priced options.

    “We’re seeing a greater increase of higher-income guests joining us this year,” Dine CEO John Peyton told CNBC, adding that the jump in traffic from that cohort is offsetting the decline in visits from low-income diners.

    High-income shoppers are also hunting for deals at retailers. Savers Value Village, which runs a chain of thrift stores across the U.S., Canada and Australia, said during its fiscal 2025 third-quarter earnings call that it’s seeing growth in both its “younger and more affluent” customer groups.

    “High household income cohort continues to become a larger portion of our consumer mix. It’s trade down for sure and our younger cohort also continues to grow in numbers,” CEO Mark Walsh said on a call with analysts in October. “We couldn’t ask for a better outcome.”

    Consulting firm Alvarez & Marsal recently conducted a consumer sentiment survey that polled over 2,000 shoppers and found 24% of respondents earning $100,000 or more a year are planning to spend less this holiday season.

    Joanna Rangarajan, a partner and managing director with the firm’s consumer and retail group, said that could partially be because they plan to trade down — or already are.

    “They’re going to pull back spending in a variety of ways. They may do that by buying fewer things, they may switch to less expensive brands, or they may switch to lower cost retailers overall, or it could be a combination of any of those things,” said Rangarajan.

    People shop at a clothing store in Manhattan on Nov. 7, 2025, in New York City.

    Spencer Platt | Getty Images

    While lower-cost brands and retailers could be seeing their core consumers spend less, it might not matter as much if they’re winning over new, higher-income shoppers.

    Walmart, in particular, has spoken about its gains among customers with an annual household income of more than $100,000. That dynamic has boosted the big-box retailer’s business for more than two years, especially as shoppers across all incomes have felt pinched by higher grocery prices. The company has also made some strategic moves to woo wealthier shoppers, such as remodeling stores, launching a new grocery brand and speeding up home deliveries.

    Even the dollar stores have attracted higher-income shoppers.

    Dollar General CEO Todd Vasos said on the company’s earnings call in late August that the retailer saw increased spending among its core customers, who tend to be lower income, despite “worsening sentiment” in the quarter that ended Aug. 1. But he added Dollar General also saw growth among middle- and high-income consumers, which “has been accelerating over the last few quarters.”

    At an investor day in mid-October, Dollar Tree CEO Michael Creedon said higher-income households are the retailer’s “fastest growing cohort.”

    Value-oriented companies, such as Walmart and warehouse clubs, are best positioned to post strong results in the coming weeks as they attract deal-hunting customers across incomes, D.A. Davidson’s Baker said.

    On the other hand, he said Target and Best Buy are in a tougher spot as they lose market share. For example, Baker said Best Buy customers are trading down to big-box stores like Walmart and club players like Costco for lower-priced TVs.

    Younger consumers pull back

    Gen Z and millennials are not spending the way that they used to as they contend with a slowing job market, rising unemployment and the resumption of student loan collection, which the federal government restarted in May.

    The generational trend is particularly bad news for fast-casual restaurants, which skew toward younger diners. Fast-casual favorites like Chipotle Mexican Grill, Cava and Sweetgreen reported that consumers aged 25 to 35 years old aren’t visiting as frequently anymore. All three chains cut their full-year forecast following disappointing third-quarter results.

    At Chipotle, the 25- to 35-year old cohort typically accounts for about a quarter of sales. However, those diners haven’t been visiting the burrito chain’s restaurants as frequently, instead opting to cook at home, according to CEO Scott Boatwright.

    “This group is facing several headwinds, including unemployment, increased student loan repayment and slower real wage growth,” he said on the company’s conference call last month.

    Beyond their fast-casual meals — known colloquially by some as “slop bowls” — younger consumers are also trying to spend less on necessities, like new glasses or contacts.

    The younger shoppers that glasses maker Warby Parker serves have been feeling “increasingly… uncertain about their future” and “more selective in their purchasing behavior,” said Warby’s co-founder and co-CEO Dave Gilboa on the company’s 2025 third quarter earnings call earlier this month.

    “We’ve seen a moderation in average order value or basket size in categories that skew younger,” said Gilboa. For example, the company has seen shoppers pull back on its higher priced frames in favor of its $95 option.

    In weakening economies, younger people can start to feel distressed earlier than older groups because they tend to earn less and have less money in savings, and are more likely to be unemployed, according to economists.

    To add to the issues, companies across the U.S. have paused hiring, which puts younger consumers who have just graduated high school or college at a particular disadvantage, according to Allison Shrivastava, a senior economist for Indeed. Plus, a stream of recent job cuts has targeted many entry-level employees, worsening employment prospects for younger workers.

    The difference in unemployment rates between younger and older people is now starker than usual, Shrivastava said. The unemployment rate for workers between 25 and 34 years old hit 4.4% in August, higher than the 3.5% rate for the 35- to 44-year old cohort and the 2.9% rates for the 45- to 54-year old and 55 years and older segments. (More recent data from the Bureau of Labor Statistics is unavailable due to the federal government shutdown.)

    Shrivastava sees the pullback in spending as largely a response to the frozen labor market.

    “We’re starting to get some frostbite in the form of declining consumer spending,” Shrivastava said, adding that “significant” layoffs could push the economy into a recession.

    Brands bucking the trends

    A shopper carries a Coach bag at an outlet mall in Commerce, California, US, on Thursday, June 27, 2024. 

    Eric Thayer | Bloomberg | Getty Images

    Though consumers have cut their spending in key areas, some companies have proved resilient because of their brand strength or the perceived quality of their products.

    Even as some younger shoppers bought fewer Chipotle burritos and Cava bowls, Coach parent Tapestry said it saw strong handbag sales in recent months — with Gen Z customers driving much of the growth.

    Tapestry, which also owns Kate Spade, raised its full-year forecast after beating quarterly sales and profit expectations.

    In an interview with CNBC, Tapestry Joanne Crevoiserat attributed that to both the popularity of the Coach brand and younger shoppers who are spending on fashion rather than other areas. She said the company’s research shows “the Gen Z consumer specifically is highly fashion engaged, spending slightly more of their budget on fashion.”

    She said the company has seen no difference in sales performance by income bracket, as it attracts shoppers from other generations as well as Gen Z.

    Coach and Kate Spade’s price points provide an edge, too, according to a note from Telsey Advisory Group. Their handbags have a significant price gap with European luxury brands — even as Tapestry brands raise price points.

    Even so, Tapestry disappointed Wall Street with a more conservative holiday-quarter outlook.

    Tapestry isn’t alone. Swiss sportswear company On and Ralph Lauren are also finding growth across all consumer segments despite a choppy economy.

    On, which reported fiscal 2025 third-quarter earnings on Wednesday, raised its full-year guidance for the third quarter in a row after seeing sales grow about 25%, bucking a slowdown in the sneaker market. 

    The company’s performance stands in stark contrast to competitors like Nike and Hoka, which are planning for either a sales decline or slowdown in growth. In late September, Nike said it was expecting sales in its holiday quarter to fall by a low single-digit percentage. Deckers, the parent company of On’s fellow buzzy footwear brand Hoka, trimmed its sales guidance for Hoka in October. 

    Meanwhile, Ralph Lauren raised its full-year outlook earlier this month after seeing sales rise 17% in its fiscal 2026 second quarter. During a call with analysts, CEO Patrice Jean Louis Louvet said it saw “balanced growth across men, women and younger cohorts.”

    Ralph Lauren is benefiting because it has a higher-income core consumer, but the company has also worked to ensure its assortment is landing with shoppers and its brand is still relevant. One of the biggest holiday trends currently hitting TikTok is a “Ralph Lauren Christmas,” which combines the brand’s old-money aesthetic with decor for those looking for a traditional holiday feel.

    “This cultural strength has also been instrumental in attracting younger consumers,” said GlobalData managing director and retail analyst Neil Saunders in a note. “Our data indicate that the brand’s penetration among younger demographics has increased. This is aided by designs such as the limited-edition Morehouse and Spelman College vintage collections, which resonate with younger consumers and play on their desire for nostalgia and heritage.”

    Dutch Bros., the fast-growing drink chain, also saw growth from younger consumers in its latest quarter. The company’s wide-ranging menu, from protein lattes to vibrant energy drinks, can be heavily customized, a feature that has proved popular with Gen Z consumers.

    “We’re seeing really incredible performance of those younger cohorts,” CEO Christine Barone said during the company’s conference call earlier this month. “I think that during times like this, customers are choosing the brands that they love most and really deciding to spend their dollars there.”

    Dutch Bros. reported quarterly same-store sales growth of 7.4%, fueled by a nearly 7% increase in traffic to its stores.

    Chili’s, which is owned by Brinker International, also saw traffic to its restaurants jump in its most recent quarter. The casual dining chain has won over diners through a turnaround strategy focused on improving the in-restaurant experience, plus savvy marketing that pitted its prices against those of fast-food chains.

    “Our customer base is very representative of the U.S. consumer across all income cohorts, but our cohort growing the fastest is actually now households with income under $60,000,” Brinker CEO Kevin Hochman said on the company’s conference call in late October.

    Others in the retail industry aren’t worried about slow spending during the holidays.

    At the malls, buzzy companies like Vuori and Alo, digitally native brands like Princess Polly and popular retailers like Abercrombie & Fitch are drawing bigger crowds as the holidays approach, said Kevin McCrain, CEO of the retail business at Brookfield Properties, one of the largest U.S. mall owners.

    Even as the economy shows blemishes, he said the company hasn’t seen a change in shopping patterns or landlord demand. And he said he still expects spending across November and December to increase from last year.

    So does the National Retail Federation. The trade group expects overall holiday spending in November and December to grow by 3.7% to 4.2% year over year and to top $1 trillion for the first time, even as shoppers scout for deals and make tradeoffs.

    Mark Mathews, chief economist at NRF, said the group’s consumer survey shows a larger percentage of shoppers are “holding off” for Black Friday and Thanksgiving weekend sales than a year ago. He added consumers are trimming back in other areas, like eating out, so they have money set aside for gifts.

    “At the end of the day, it’s the holiday season,” Brookfield’s McCrain said. “People get caught up in the lights and Santa Claus, and everyone wants to be positive and hopeful and just have a great time.”

    Continue Reading

  • Dear Apple, Please Don’t Ruin the Health App by Slapping a Siri Button on It

    Dear Apple, Please Don’t Ruin the Health App by Slapping a Siri Button on It

    Apple’s reportedly prepping a new Health app for next year, possibly dropping alongside Siri’s long-awaited makeover. The combo could finally make the Apple Watch feel truly hands-free, with Siri integrated more deeply into daily health tracking….

    Continue Reading

  • Android Developer Verification Starts As Google Partially Retreats On Measures

    Android Developer Verification Starts As Google Partially Retreats On Measures

    In a recent blog post Google announced that the early access phase of its Android Developer Verification program has commenced, as previously announced. In addition to this new announcement Google also claims to be taking note of the…

    Continue Reading

  • Wild Polio Virus Confirmed in Hamburg, Germany Wastewater — Vax-Before-Travel

    Wild Polio Virus Confirmed in Hamburg, Germany Wastewater — Vax-Before-Travel

    Hamburg (Vax-Before-Travel News)

    In its latest update, the Robert Koch Institute (RKI) has confirmed the detection of wild poliovirus type 1 (WPV1) in Hamburg, Germany, home to about two million people.

    The RKI says regular testing of wastewater…

    Continue Reading